Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3KÎ´ inhibitors.
Qin, Lan-Ying; Ruan, Zheming; Cherney, Robert J; Dhar, T G Murali; Neels, James; Weigelt, Carolyn A; Sack, John S; Srivastava, Anurag S; Cornelius, Lyndon A M; Tino, Joseph A; Stefanski, Kevin; Gu, Xiaomei; Xie, Jenny; Susulic, Vojkan; Yang, Xiaoxia; Yarde-Chinn, Melissa; Skala, Stacey; Bosnius, Ruth; Goldstein, Christine; Davies, Paul; Ruepp, Stefan; Salter-Cid, Luisa; Bhide, Rajeev S; Poss, Michael A.
Bioorg Med Chem Lett
; 27(4): 855-861, 2017 02 15.
Artigo em Inglês | MEDLINE | ID: mdl-28108251
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3KÎ´ inhibitors.
Synthesis and biological evaluation of novel 7-substituted 3-(4-phenoxyphenyl)thieno[3,2-c]pyridin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors.
Identification of highly potent and selective PI3KÎ´ inhibitors.
Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors.
Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.
Hologram QSAR models of a series of 6-arylquinazolin-4-amine inhibitors of a new Alzheimer's disease target: dual specificity tyrosine-phosphorylation-regulated kinase-1A enzyme.
Identification of GNE-293, a potent and selective PI3KÎ´ inhibitor: navigating in vitro genotoxicity while improving potency and selectivity.
Synthesis and PI3 Kinase Inhibition Activity of Some Novel Trisubstituted Morpholinopyrimidines.
Identification of novel PI3K inhibitors through a scaffold hopping strategy.
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.